Trials / Completed
CompletedNCT00721201
Glucocorticoid Receptor Antagonism in Subclinical Cushings
A Pilot Study of the Effect of a Glucocorticoid Receptor Antagonist in Patients With Subclinical Cushings
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effects of reducing the activity of endogenous glucocorticoid in patients with low-grade cortisol excess
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mifepristone | Use of mifepristone 200mg bd for 8 weeks |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2008-07-23
- Last updated
- 2021-01-26
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00721201. Inclusion in this directory is not an endorsement.